| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABT-737, a BH3 mimetic, induces glutathione depletion and oxidative stress
|
Howard, Adrienne N.
|
|
2009
|
65 |
1 |
p. 41-54
|
artikel
|
| 2 |
A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors
|
Saridaki, Zacharenia
|
|
2009
|
65 |
1 |
p. 121-128
|
artikel
|
| 3 |
A dose-finding and pharmacokinetic study of nedaplatin in elderly patients with advanced non-small cell lung cancer
|
Yamamoto, Noboru
|
|
2009
|
65 |
1 |
p. 79-88
|
artikel
|
| 4 |
A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors
|
Muindi, Josephia R.
|
|
2009
|
65 |
1 |
p. 33-40
|
artikel
|
| 5 |
A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer
|
Furuse, Junji
|
|
2009
|
65 |
1 |
p. 113-120
|
artikel
|
| 6 |
A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma
|
Chen, Jen-Shi
|
|
2009
|
65 |
1 |
p. 151-157
|
artikel
|
| 7 |
Biological reactive intermediates that mediate dacarbazine cytotoxicity
|
Pourahmad, Jalal
|
|
2009
|
65 |
1 |
p. 89-96
|
artikel
|
| 8 |
Combination analyses of anti-cancer drugs on human neuroendocrine tumor cell lines
|
Larsson, Dhana E.
|
|
2009
|
65 |
1 |
p. 5-12
|
artikel
|
| 9 |
Hepatic portal venous gas in a patient with metastatic non-small cell lung cancer on bevacizumab therapy: a case report and review of the literature
|
Ortega, Jose
|
|
2009
|
65 |
1 |
p. 187-190
|
artikel
|
| 10 |
K-ras status in squamous cell anal carcinoma (SCC): it’s time for target-oriented treatment?
|
Zampino, Maria Giulia
|
|
2009
|
65 |
1 |
p. 197-199
|
artikel
|
| 11 |
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors
|
Denlinger, Crystal S.
|
|
2009
|
65 |
1 |
p. 97-105
|
artikel
|
| 12 |
Pharmacokinetics of temozolomide administered in combination with O6-benzylguanine in children and adolescents with refractory solid tumors
|
Meany, Holly J.
|
|
2009
|
65 |
1 |
p. 137-142
|
artikel
|
| 13 |
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies
|
Lin, Chia-Chi
|
|
2009
|
65 |
1 |
p. 167-175
|
artikel
|
| 14 |
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers
|
Dowlati, Afshin
|
|
2009
|
65 |
1 |
p. 73-78
|
artikel
|
| 15 |
Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer
|
Lee, Sung-Ji
|
|
2009
|
65 |
1 |
p. 159-166
|
artikel
|
| 16 |
Phase I study of larotaxel administered as a 1-h intravenous infusion every 3 weeks to Japanese patients with advanced solid tumours
|
Yamamoto, Nobuyuki
|
|
2009
|
65 |
1 |
p. 129-136
|
artikel
|
| 17 |
PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin
|
Yuan, Zhu
|
|
2009
|
65 |
1 |
p. 13-25
|
artikel
|
| 18 |
Preclinical pharmacokinetics and in vitro activity of ON 01910.Na, a novel anti-cancer agent
|
Chun, Amy W.
|
|
2009
|
65 |
1 |
p. 177-186
|
artikel
|
| 19 |
Preclinical pharmacokinetics and in vitro metabolism of brivanib (BMS-540215), a potent VEGFR2 inhibitor and its alanine ester prodrug brivanib alaninate
|
Marathe, Punit H.
|
|
2009
|
65 |
1 |
p. 55-66
|
artikel
|
| 20 |
Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients
|
Cassileth, Barrie R.
|
|
2009
|
65 |
1 |
p. 67-71
|
artikel
|
| 21 |
Successful desensitization with cetuximab after an infusion reaction to panitumumab in patients with metastatic colorectal cancer
|
Saif, Muhammad Wasif
|
|
2009
|
65 |
1 |
p. 107-112
|
artikel
|
| 22 |
The polyamine analog PG11047 potentiates the antitumor activity of cisplatin and bevacizumab in preclinical models of lung and prostate cancer
|
Dredge, K.
|
|
2009
|
65 |
1 |
p. 191-195
|
artikel
|
| 23 |
The potential of vitamin K3 as an anticancer agent against breast cancer that acts via the mitochondria-related apoptotic pathway
|
Akiyoshi, Takeshi
|
|
2009
|
65 |
1 |
p. 143-150
|
artikel
|
| 24 |
UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib
|
Meza-Junco, Judith
|
|
|
65 |
1 |
p. 1-4
|
artikel
|
| 25 |
UGT1A1 polymorphism and hyperbilirubinemia in a patient who received sorafenib
|
Meza-Junco, Judith
|
|
2009
|
65 |
1 |
p. 1-4
|
artikel
|
| 26 |
Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck
|
Cho, Byoung Chul
|
|
2009
|
65 |
1 |
p. 27-32
|
artikel
|
Tijdschrift beschrijving